Chiasma (CHMA) Q2 2020 Earnings Call Transcript
Except as required by law, Chiasma disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events, or otherwise. Joining the call today is Raj Kannan, chief executive officer; Anand Varadan, executive vice president and chief commercial officer; Bill Ludlam, senior vice president of clinical development and medical affairs; and Mark Fitzpatrick, president and principal financial officer.
